Objective: The purpose of the study was to estimate the prevalence of attention-deficit/hyperactivity disorder (ADHD) and its clinical characteristics in the Northern Finland Birth Cohort 1986. Method: A general population Northern Finland Birth Cohort 1986 of 9,432 children followed prospectively from the early fetal period was surveyed at adolescence (ages 16Y18) for ADHD behaviors. Among 6,622 respondents to the survey, a subset of 457 likely cases and controls were evaluated for ADHD and other psychiatric disorders. Chi-square and descriptive statistics were used to examine clinical characteristics of ADHD in the subset, and logistic regression was used to estimate prevalence by weighted extrapolation in the larger cohort. Results: The estimated prevalence of ADHD among adolescents in the Northern Finland Birth Cohort 1986 is 8.5%
numerous psychiatric and learning disorders. Family and twin studies during the past decades support the hypothesis that ADHD represents an extreme along an underlying continuum of liability in the population with genetic contributions estimated at about 76% (Faraone et al., 2005) . It remains unclear what factors best measure the liability continuum associated with ADHD (e.g., attention, disinhibition, memory, temperament) and what the underlying brain biology and genetics are that interact with environment in its development.
The prevalence of ADHD has increased across diagnostic classification systems as a greater proportion of individuals falling along the liability continuum are recognized as experiencing impairment warranting clinical support (Skounti et al., 2007) . Prevalence rates vary across populations from 2.2% to 16.1% with variability inf luenced by diagnostic criteria, number and type of informants, degree of impairment, age and sex of the population, and clinical versus community cohorts (Faraone et al., 2003; Skounti et al., 2007) . Although most epidemiological studies have centered on children, recent studies have found prevalence rates of ADHD among adolescents to be comparable (range 2.2%Y9.9% [Skounti et al., 2007] ), although several prospective studies support a decline in prevalence from childhood to adolescence (Breton et al., 1999; Cohen et al., 1993; Gomez-Beneyto et al., 1994; Nolan et al., 2001) .
ADHD is often comorbid with other psychiatric (oppositional disorder, mood, anxiety, substance abuse/ dependence) and learning disorders (dyslexia, executive function deficits), yet specific mechanisms underlying the comorbidity are still poorly understood. The prevalence of psychiatric disorders within ADHD samples across populations has been less rigorously investigated but may shed light on emerging findings of genetic differences (linkage and candidate gene studies) between populations that may reflect clinical and/or etiological differences.
The Northern Finland Birth Cohort (NFBC) Study of ADHD was initiated in July 2001 to identify risk genes underlying ADHD and to explore gene Â environmental interactions in its development using a population-based sample of adolescents who had been followed prospectively from the fetal period (Järvelin et al., 1993) . The cohort is drawn from northern Finland (population 630,000) that consists of an early and a late settlement, the latter of which is a unique isolate within Finland where individuals descended from a small number of families who migrated there in the 17th century and expanded locally and have proved invaluable to genetic studies of monogenic and complex traits (Hovatta et al., 1999; Peltonen et al., 1999; Varilo and Peltonen, 2004) . This article represents an investigation into the prevalence and psychiatric comorbidity of ADHD in this adolescent population to begin to lay the foundation for subsequent genetic and environmental investigations.
METHOD

Sample and Screening Procedures
All of the subjects and their parents participating in the present follow-up study of NFBC 1986 provided informed consent for the survey and clinical assessment under procedures approved by the University of Oulu and University of California, Los Angeles Institutional Review Boards. A screening instrument for ADHD, the Strengths and Weaknesses of ADHD-Symptoms and NormalBehavior (SWAN) scale (Swanson et al., 2001) , was included in the parents_ questionnaire of the 9,215 adolescents whose address was known at 15 years of age. The parents of 6,985 (75.8%) adolescents returned the questionnaires, and in 6,622 cases, the screening instrument had been completed sufficiently and the parents had given permission to use their data (2,230 parents failed to return the questionnaire, 119 refused to have their data used, 224 had missing data). A comparison of respondents to nonrespondents for the current survey was made using behavioral assessments based on the Rutter B scale (Rutter, 1967) at ages 7 to 8. The means were nominally different (respondent_s mean 3.5, SD 4.8; nonrespondent_s mean 4.5, SD 5.5) with a Cohen_s d effect size of 0.18.
The SWAN was selected as a screening tool because, unlike typical diagnostic checklists for ADHD (e.g., the SNAP [Swanson, 1995] ) that discriminate clinically significant behavior from nonclinical samples, the SWAN (Swanson et al., 2001) yields information on population variability of items reflecting dimensions of attention, impulsivity, and hyperactivity. At the same time, while providing adequate screening for ADHD, SWAN and SNAP-IV questionnaires have been shown to identify the same set of children with ADHD (Swanson et al., 2001) and to perform well in population molecular genetic studies of ADHD (Cornish et al., 2005 ). An examination of the properties of the SWAN scores in the full cohort is found in Lubke et al. (2007) .
The SWAN scores were used to identify likely ADHD cases among the NFBC by requiring SWAN scores to exceed the upper 95% percentile on either Combined, Inattentive, or Hyperactive-Impulsive scales and controls by requiring all three SWAN scores to fall below the 90th percentile. Individuals falling between the 90th and 95th percentiles were available for additional sampling as potential cases if adequate numbers were not available from the 95% percentile and above. No subjects were recruited from this group over the course of the study period because logistics precluded additional subject participation. A flowchart depicting the sampling schema is shown in Figure 1 .
A sample of 487 SWAN cases were invited to participate in a direct clinical assessment, and a sample of 315 SWAN controls were invited to participate that group-matched the cases by geographical location, sex, and birth year. The 487 SWAN cases represented all of the adolescents meeting SWAN criteria who were living in Oulu province and Lapland; logistics precluded assessment of any subjects outside these targeted geographic regions. We sampled more cases than controls because a key objective of the research was to identify a large sample of ADHD adolescents for genealogical reconstruction and genetic linkage studies with a smaller sample of controls for caseYcontrol comparisons. As shown in Figure 1 , 268 (55%) of SWAN cases invited to participate in the direct interview and 196 (62%) of invited SWAN controls agreed to do so. There were no significant differences on SWAN scale scores for participants and nonparticipants in the direct interview (data not shown).
Clinical Assessment
The 268 SWAN-defined cases and 196 SWAN-defined controls that agreed to participate completed the clinical assessment that included a psychiatric evaluation using the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL; Kaufman et al., 1997) . The K-SADS-PL is a highly reliable semistructured interview for the assessment of a wide range of psychiatric disorders including ADHD. The interview was conducted by mental health specialists trained in its administration, first with the primary caretaker and then with the adolescent, with information from both informants combined to determine a consensus diagnosis. If informant discrepancies are present, then further probing is conducted to determine a consensus rating based on clinical judgment. It is widely used in studies of ADHD and has been the primary instrument of assessment in our ongoing genetic studies of ADHD at UCLA (Smalley et al., 2000) . Intrasite reliability was established for lifetime ADHD (probable or definite; 0 = .78 [SE 0.09] ) and other diagnoses (mean 0 = .77 and .96, SE 0.04). The intersite reliability was maintained through an independent rerating of each subject_s material by the U.S. clinical team using case summaries and diagnostic packets prepared in English by the Finnish clinicians. A best estimate procedure was used to determine final diagnosis (Leckman et al., 1982) . All of the original interviews and reratings were done blind to the SWAN diagnostic status. Intersite reliability, determined from initial best estimate diagnosis and the final consensus diagnosis was .87 for childhood ADHD (based on symptoms occurring by age 12) and .90 for current ADHD (ages 16Y18). The average 0 for other psychiatric diagnoses was .94 (range .82Y.96).
DSM-IV criteria were used to determine ADHD either currently (in adolescence) or in the past (in childhood) defined from retrospective recall of behaviors before age 12 years. Childhood diagnoses of ADHD were based on retrospective recall for the most part because the prospective assessments at age 7 to 8 had only a few items directly targeting ADHD based on the Rutter B scale (Rutter, 1967) . These items were included in best estimate diagnoses as collateral information to retrospective information in ensuring accuracy of diagnoses. We selected age 12 to probe for childhood behaviors because this age marks a developmental period of childhood to adolescence and was useful for anchoring the time period to collect retrospective information; however, symptoms had to be evident by age 7 to meet DSM-IV criteria. Following our diagnostic system in the UCLA Genetic Study of ADHD (Smalley et al., 2000) , a definite diagnosis was made if a subject met all of the criteria for ADHD and a probable diagnosis was made if a subject fell one symptom short of criteria but met criteria for impairment and age at onset. We include a probable diagnosis of ADHD using these less stringent criteria because they may capture individuals falling short of diagnosis but more extreme on the liability continuum and thus helpful for genetic investigations. Of the 464 subjects who participated in the clinical interview ( Fig. 1 ), seven were excluded from analyses because of comorbid mental retardation (IQ <70, n = 2), autism (n = 1), or known genetic anomalies (neurofibromatosis, n = 1; trisomy X, n = 1; metabolic disorders, n = 2). The 457 subjects remaining were classified into diagnostic categories (no diagnosis, probable, definite) using childhood information (past childhood) and current behavior (current adolescent). The distribution of subjects is shown in Table 1 .
In addition to past and current classification, a broad lifetime diagnosis was made that included any subject with either childhood or adolescent, probable or definite ADHD. Referring to Table 1 , the broad lifetime ADHD diagnosis includes all subjects (n = 188) except those in the no diagnosis cell (n = 269). This lifetime ADHD diagnosis is also the classification scheme reflected in Figure 1 , boxes C, D, E, and F. ADHD subtype was determined for both past childhood and current adolescent diagnoses following the DSM-IV criteria for subtype. In the case of a probable diagnosis, the subtype was determined using five or more symptoms rather than six.
Analyses
The NFBC has a well-established database and management system in place. All questionnaire and direct interview data were entered using a double-entry method and were further cleaned and reviewed for outliers or potential errors resulting from changes generated through the best estimate procedures at University of Oulu and at University of California, Los Angeles.
For the various definitions of ADHD shown in Table 1 , we used a weighted logistic regression model to estimate the prevalence by sex in the whole cohort and then used sex-specific means of the predicted probabilities. Specifically, a weighted logistic regression model was fitted on the data from subjects participating in the clinical assessment so that they had both a best estimate diagnosis and SWAN data. The ADHD diagnosis (yes or no) according to the best estimate was used as the outcome, with sex, the mean HI score, and the mean I score of the SWAN scale being used as the predictor variables, including interaction terms (sex and the mean HI and I scores), if significant. Note: Numbers in brackets reflect percentage of subjects who were classified as SWAN cases based on the screening criteria. ADHD = attention-deficit/hyperactivity disorder; NFBC = The Northern Finland Birth Cohort; SWAN = Strengths and Weaknesses of ADHD-Symptoms and Normal-Behavior Scale.
a These cases failed to meet definite or probable ADHD diagnosis based on retrospective report of behaviors in childhood; however, all of them had sufficient evidence of some symptoms by age 7 to meet the age of onset criteria. The weights were assigned according to the observed sampling fractions: the weight for each participating SWAN case subject was 530/261, and that for each SWAN control subject was 5694/196. The predicted probabilities from the fitted model were then computed for all of the 6,622 cohort members providing data on SWAN. The estimates of the ADHD prevalence in the whole cohort were then computed by the means of the predicted probabilities. The variance of the estimated prevalences was estimated by calculating robust variance estimates, also known as the Huber and White estimates (see StataCorp, 2001 ). These statistical procedures were computer in Stata version 9, and the modeling performed in Stata command logistic with p weights.
To explore the associations between the factors of interest, analysis of variance was used to test mean differences for continuous variables and x 2 tests or Fisher exact probability test was used to test equalities of proportions as appropriate. Logistic regression (run by either SPSS 10.0.1 or SAS 9.1.3) was also used to evaluate the role of factors such as ADHD and sex on rates of comorbid psychiatric disorders observed in the sample. Given the large number of test comparisons, a p value of .01 was adopted for determining significance level.
RESULTS
SWAN Screening
The 6,622 NFBC adolescents (3,314 male) with SWAN data are depicted in Figure 2aYc for the three SWAN scales: C, I, HI. The 95% cutoffs values were .278 (Combined), .625 (Inattentive), and .125 (HyperactiveImpulsive) based on the full distribution of respondent_s questionnaire scores. Males and females differed in SWAN scores for all of the dimensions (Combined, Inattentive, and Hyperactive-Impulsive) as noted in Figure 2 , with males demonstrating higher average SWAN scores.
ADHD Prevalence in the NFBC
The prevalence of Definite DSM-IV ADHD among adolescents is 8.5%, whereas retrospective childhood ADHD has a prevalence of 12.6%, as shown in Table 2 . It should be noted that more stringent criteria (requiring a definite diagnosis based on both childhood and adolescence) yield a prevalence of 6.7%. Male/female odds ratios (ORs) for these three classification schema are 5.7, 5.2, and 6.1, respectively. The subtype distribution among current definite ADHD cases was 67 Inattentive (64%), 30 Combined (28%), and 8 HyperactiveImpulsive (8%; see Hurtig et al., 2007 , for details). The broad lifetime ADHD has a prevalence of 18.2% and a male/female odds ratio of 3.2, reflecting the increased proportion of girls falling short of full criteria for DSM-IV.
We use the broad definition of lifetime ADHD (n = 188 adolescents; boxes D and F in Figure 1 ), for subsequent analyses as it is comparable to that used in our genome-wide investigations of ADHD in the U.S. population (Ogdie et al., 2004) .
Psychiatric Comorbidity
We compared the frequency of comorbid psychiatric disorders across the three groups using the broad lifetime ADHD classification coupled with the SWAN screening information (refer to Table 3 , there are differences in the general categories of anxiety disorders (p = .01), mood disorders (p = .0003), substance abuse/dependence (p e .0001), and disruptive disorders (p e .0001), with the ADHDaffected group exhibiting the highest rates. Specific psychiatric disorders differ between the groups include major depressive disorder, posttraumatic stress disorder (PTSD), oppositional defiant disorder (ODD), conduct disorder (CD), and substance abuse or dependence.
We tested the association of ADHD with psychiatric comorbidity by using logistic regression to compare the ADHD cases (again boxes D and F) to stringent controls (box E). ADHD and sex were entered in all of the models to examine associations with psychiatric disorders a The odds ratios and their 95% confidence intervals (CIs) were calculated from the main effect models that included no interactions between sex and the Inattentive/Hyperactive-Impulsive mean scores. showing significant differences (p < .01) in the casecontrol comparisons. In addition, ODD and CD were included as independent variables for all disorders (except ODD and CD) following a similar analytic approach used in ADHD adults (McGough et al., 2005) . Results from these logistic regressions are shown in Table 4 .
As can be seen in the table, ADHD is associated with any mood disorder (OR 2.9), any anxiety disorder (OR 2.4), and any disruptive behavior disorder (OR 17.3). Specific disorders associated with ADHD status include PTSD (OR 22.6), major depression (OR 2.5), CD (OR 14.8), and ODD (OR 10.4). There was a consistent effect of sex (with female/male OR >1) for all psychiatric comorbid disorders except CD and substance abuse/ dependence (no sex differences detected for these). Substance abuse, although elevated in the ADHD sample, is associated more strongly with the comorbid disorder of CD (OR 16.7) than ADHD.
The data also allowed us to examine the group of adolescents with elevated SWAN scores who did not meet criteria for ADHD based on direct interview (box C) compared to the stringent control group (box E). Logistic regression revealed that only two disorders differed significantly across the groups: CD ( p = .003, OR 5.1, 95% CI = 1.8Y14.5) and ODD ( p = .0003, OR 10.5, 95% CI = 2.9Y37.3), suggesting that this group of adolescents had significantly elevated disruptive disorders compared to controls. The mean number of Note: The column headings represent groups identified through SWAN screening (SWAN case, SWAN control) and direct psychiatric evaluation (ADHD or unaffected) using best estimate procedures and the broad lifetime diagnosis. The SWAN case, unaffected represents a group of adolescents who fell short of an ADHD diagnosis by clinical interview but scored in the upper 95% percentile on SWAN screening. The ADHD affected group represents all of the cases meeting broad lifetime ADHD diagnosis regardless of SWAN screen classification. The stringent control group represents adolescents who were classified as controls by SWAN screening and were classified as unaffected by direct interview. p <.01. Fisher exact test was used for expected frequencies <5. Boxes with the same letter (a, b, c) are statistically different at " = .05 level and represent pairwise comparisons between each box. NFBC = Northern Finland Birth Cohort; ADHD = attention-deficit/hyperactivity disorder; SWAN = Strengths and Weaknesses of ADHD-Symptoms and Normal-Behavior Scale; PTSD = posttraumatic stress disorder; OCD = obsessive-compulsive disorder; MDD = major depressive disorder; CD = conduct disorder; ODD = oppositional defiant disorder; PDD = pervasive developmental disorder.
a Includes adjustment disorder for depressed mood, seasonal affective disorder, and depressive not otherwise specified.
ADHD symptoms also differed between the groups with the SWAN case/ADHD unaffected adolescents having higher mean scores on both Inattentive and HyperactiveImpulsive symptom counts (1.6 and 1.2, respectively) compared to controls (0.7 and 0.4, respectively; Wilcoxon test Inattentive symptoms, z = 5.8, p < .0001; Hyperactive-Impulsive symptoms, z = 5.4, p < .0001), suggesting that they are elevated in ADHD symptoms compared to the general population, but lacking in sufficient symptom number to meet DSM-IV criteria.
DISCUSSION
Investigation of ADHD in the NFBC adolescent cohort yields several important findings for understanding the prevalence of ADHD and its clinical phenomenology cross-culturally. First, ADHD is a common disorder among adolescents in northern Finland with an estimated prevalence of 8.5%, consistent with rates of ADHD noted in other studies of adolescents. For example, a rate of 9.9% was obtained for female twins ages 13.5 to 19.5 in a U.S. study (Hudziak et al., 1998) , a rate of 5.8% was found in 12-to 14-year-olds in Brazil (Rohde et al., 1999) , and 15% in 14-to 18-year-olds in a third U.S. study (DuPaul et al., 1998) .
As can be seen in the present study, prevalence can vary (in this study, 6.7%Y8.5%) depending on how criteria are applied for a disorder that has its origins in childhood and can continue through adulthood. Furthermore, a shift in diagnostic classification from definite to probable yields a substantially higher prevalence (18.7%) even though impairment and age at onset criteria were still required. A comparable sort of substantial change is reported by Wolraich et al. (1998) when impairment was added to criteria (reduction in prevalence from 16.1% to 6.8%).
A difference in prevalence with more boys than girls was indicated across all classification schema, but the difference in odds ratios (male:female) was more striking (5.2Y6.1) for the definite classification than the broad (probable or definite) classification (3.2). In adolescence, the sex difference in prevalence is generally less than in childhood and lower in community versus clinical samples (Skounti et al., 2007) , with ratios in the former ranging from 1:1 to 3:1 and as high as 9:1 for clinical. The current finding falls somewhat above that found in population samples. One explanation for this finding might be a bias of males with difficulties to come into the clinical assessment than females, although participants and nonparticipants did not differ significantly in the SWAN scores, so other factors (impairment level not detected by SWAN) may be an issue. It should be noted that the 95% CIs of the ORs of prevalence estimates are large enough to include the majority of population ratios reported in other studies. It is of interest to note that in the present study, the OR drops to 3.2 under the broad lifetime classification from 5.2 under the definite adolescent classification. These data suggest that adolescent girls may show fewer symptoms than boys but still meet impairment and age at onset criteria and may be missing a clinical diagnosis (relative to boys) by applying the same threshold. Because ADHD is seen as an extreme on a normal continuum of liability, determining where a Note: Stepwise logistic regressions using disorders that showed a significant association (p < .01) with ADHD group status. All of the models include as predictors ADHD, sex, CD, and ODD and possible interactions (for CD and ODD, only ADHD and sex are included). Significant predictors are shown and listed in the order in which they entered the model. The odds ratios are given as presence of disorder to no disorder and female to male for order of effect. ADHD = attention-deficit/hyperactivity disorder; OR = odds ratio; CI = confidence interval; PTSD = posttraumatic stress disorder; CD = conduct disorder; MDD = major depressive disorder; ODD = oppositional defiant disorder.
threshold needs be drawn on that continuum will have important clinical implications (treatment or not) but not necessarily etiological distinction.
The ADHD subtype classifications were comparable to those found in other studies of adolescents. For example, Nolan et al. (2001) reported a distribution of 78% Inattentive, 5% Hyperactive-Impulsive, and 17% Combined, whereas DuPaul et al. (1998) found rates of 70%, 11%, and 19%, respectively. Again, the Inattentive subtype predominates among adolescents in these studies consistent with that reported in the present sample. A different pattern is present among children and a detailed analysis of these changes can be seen in the article by Hurtig et al. later in this special section.
The lifetime diagnosis of ADHD is strongly associated with psychiatric comorbidity in the adolescent population consistent with studies of ADHD in adulthood in the United States (McGough et al., 2005) . Most notably, there is a significant risk for disruptive behavioral disorders with an approximate 17-fold risk increase relative to non-ADHD controls. Similarly, ADHD is associated with anxiety and mood disorders, specifically PTSD and major depression. The OR for major depression is threefold higher in ADHD than non-ADHD controls, whereas that of PTSD is 22-fold higher. The latter finding needs to be interpreted with caution given the small sample size and wide CIs. Nevertheless, the relationship of PTSD and ADHD was indicated in our study of ADHD in adults (McGough et al., 2005) and a recent report of adolescent ADHD (Kessler et al., 2005) , suggesting that future research on PTSD and ADHD is warranted. The association may be due to ADHD increasing the risk for PTSD (e.g., if impulsivity increases risk of exposure to environmental trauma) and/ or a shared risk factor contributing to both. The association of ADHD and Substance Abuse/Dependence in the present sample seems largely accounted for by the strong overlap of CD and ADHD.
The data support the presence of ADHD in the NFBC and the comparability of ADHD in this population with other population samples. Such similarities in comorbidity and course suggest that the relative homogeneity of northern Finland does not alter the clinical expression of ADHD. One of the most interesting aspects of the NFBC is the relatively low use of stimulant medication for the treatment of ADHD; none of the adolescents had been or were being treated with stimulant medication. Finland and the United States differ in many ways beyond the use of psychostimulant medication in the treatment of ADHD, including the presence of early detection and psychosocial interventions, made possible via comprehensive public health care in Finland. Other factors (e.g., poverty, urban crowding) may contribute to such differences in treatment approaches that are beyond the scope of this article. This unique stimulant medicationY naïve sample of adolescents with ADHD allows for evaluation of the life course of ADHD in individuals who have not been treated with medication.
Limitations
We had a 70% response rate to the survey and a 55% participation rate in the direct interview. This reduced participation of the cohort is a limitation of the study. We determined from the data collected as a 7-to 8-year assessment that there were nominal differences in behavior (means differed with an effect size of 0.18) among respondents and nonrespondents to the survey, and there were no differences in SWAN scores among participants in the direct interview compared to those who did not participate in the direct interview. These findings suggest that the findings of the present study in a selected subset of adolescents are not likely biased, although other sources of differences may be present and not detected. Also, although ADHD and psychiatric diagnoses were determined by clinicians blind to screening status, they may be more highly rated in the present study overall because the study was designed to find ADHD cases for genetic investigation. The clinical team is experienced in diagnoses, but there were no teacher reports included in the best estimate procedures so that diagnoses were based only on parent and child reports. Information collected at age 7 to 8 years (Rutter B scale items of hyperactivity and inattention) was used to supplement material in the best estimate procedure, however, to help validate the diagnosis. Second, the findings for the NFBC may not generalize to other populations; however, the similarity in ADHD characteristics (sex distribution, subtype distribution, psychiatric comorbidity) with other epidemiological studies suggests that the present findings may be robust across other populations. Last, the prevalence rate is determined, in part, by the screening instrument, its sensitivity and specificity, and our choice of sampling strategies (i.e., upper 95th percentile). Alternative surveys and/or selection criteria may lead to different prevalence estimates.
Clinical Implications
ADHD is a common disorder that may present fully in childhood or in some cases may show signs and symptoms by age 7 but not be present fully until later in development. A much larger sample of individuals at risk may fall short of diagnosis but still have impairment and show the chronicity of symptoms throughout childhood and adolescents. This may be particularly true of girls during adolescence. Given that the underlying liability of ADHD is continuous in the population, it is perhaps important to recognize the quantitative nature of the trait underlying ADHD and work toward preventing impairment in a much larger sample using nonclinical approaches. From a clinical perspective, those at-risk individuals may present with a variety of psychiatric disorders, most notably disruptive disorders, mood, anxiety, and substance abuse/dependence, but fail to meet full DSM-IV criteria, and yet be high on the liability scale. This has important implications for early identification and prevention.
